Myriad Genetics, Inc. (NASDAQ:MYGN) price is hovering higher on Wednesday, May 08, jumping 17.80% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $19.78. Taking into account the 52-week price action we note that the stock hit a 52-week high of $24.21 and 52-week low of $13.82. The stock added 11.59% on its value in the past month.
On average, analysts have forecast the company’s revenue for the quarter will hit 204.05M, with the likely lows of 198.5M and highs of 210.5M. Staying with the analyst view, there is a consensus estimate of 826.61M for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow 9.70% above that which the company brought in the current year earning report.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give MYGN a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.
The overview shows that MYGN’s price is at present 21.60% off the SMA20 and 12.91% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 72.51, with weekly volatility standing at 4.59%. The indicator jumps to 3.96% when calculated based on the past 30 days. Myriad Genetics, Inc. (NASDAQ:MYGN)’s beta value is holding at 1.94, while the average true range (ATR) indicator is currently reading 1.06.
An analysis of the Myriad Genetics, Inc. (NASDAQ:MYGN) stock in terms of its daily trading volume indicates that the 3-month average is 662.03K.
Current records show that the company has 89.90M in outstanding shares. The insiders’ percentage holdings are 4.29% of outstanding shares while the percentage share held by institutions stands at 102.00%. But the 21.73% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
